YGH-93011-92887
2 vaccinations
10 coded responses
25 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 214 / MD
- Registered
- 2021-08-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-06
Registered in v-safe
-
2021-08-06
Dose 1 — Moderna
-
2021-08-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-08-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-08-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-12
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sore throat, congestionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-13
Survey response — day 7, dose 1MedDRA: Ear discomfort, Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tirednessFree text: Full ears, congestionMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-20
- 2021-08-27
- 2021-09-03
- 2021-09-10
-
2021-09-17
Survey response — day 42, dose 1MedDRA: Fatigue, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: FairFree text: Sore throat, postnasal drip, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-09-24
Dose 2 — Moderna
-
2021-09-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-27
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Respiratory tract congestion — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Congestion, shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Mental disorder — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Shortness of breath, mentally unwellMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — day 7, dose 2MedDRA: Brain fog, Dyspnoea — Feeling: Fair · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Shortness of breath, mental fogMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
-
2021-10-15
Survey response — day 21, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-10-22
- 2021-10-30
- 2021-11-06
-
2021-12-24
Survey response — 3 months, dose 2MedDRA: Migraine, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Migraines, sore throat, postnasal dripMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-06 | Moderna | No |
| 2 | 2021-09-24 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat, congestion
Release 9 — day 7, dose 1
Systemic reaction (other): Full ears, congestion
Release 9 — day 42, dose 1
Symptoms: Sore throat, postnasal drip, fatigue
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Congestion, shortness of breath
Systemic reaction (other): Shortness of breath
Systemic reaction (other): Shortness of breath, mentally unwell
Systemic reaction (other): Shortness of breath
Release 9 — day 7, dose 2
Systemic reaction (other): Shortness of breath, mental fog
Release 10 — day 21, dose 2
Symptoms: Severe fatigue
Release 10 — 3 months, dose 2
Symptoms: Migraines, sore throat, postnasal drip
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Ear discomfort | ✓ | · | ✓ |
| SRO | Mental disorder | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | · | ✓ |
| SRO | Respiratory tract congestion | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release